EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Low- to moderate-dose thalidomide combination rescue after luspatercept failure in transfusion-dependent β-thalassemia: a real-world cohort study

Soulivanh Nanthachak, Cailan Wen, Zhaoping Gan, Lingyuan Pan, Rongrong Liu, Yumei Huang

Annals of Hematology · 2026

DOI: 10.1007/s00277-026-07100-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Hematology, 2026. Verfasst von Soulivanh Nanthachak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China. Hauptthemen laut MEDLINE: Thalidomide, beta-Thalassemia, Recombinant Fusion Proteins, Activin Receptors, Type II. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thalidomidebeta-ThalassemiaRecombinant Fusion ProteinsActivin Receptors, Type IIImmunoglobulin Fc FragmentsBlood TransfusionHumansFemaleMaleRetrospective StudiesAdultYoung AdultCohort StudiesDrug Therapy, CombinationTreatment Failure

Stichwörter der Autor:innen

Combination therapyLuspaterceptRescue strategyThalidomideTransfusion independenceTransfusion-dependent β-thalassemia

Substanzen

ThalidomideluspaterceptRecombinant Fusion ProteinsActivin Receptors, Type IIImmunoglobulin Fc Fragments

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • NHC Key Laboratory of Thalassemia Medicine, Nanning, Guangxi, 530021, China. liurongrong@stu.gxmu.edu.cn.
  • Guangxi Key Laboratory of Thalassemia Research, Nanning, Guangxi, 530021, China. liurongrong@stu.gxmu.edu.cn.
  • Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China. liurongrong@stu.gxmu.edu.cn.
  • Education Department of Guangxi Zhuang Autonomous Region, Key Laboratory of Hematology, Guangxi Medical University, Nanning, Guangxi, 530021, China. liurongrong@stu.gxmu.edu.cn.
  • NHC Key Laboratory of Thalassemia Medicine, Nanning, Guangxi, 530021, China. yumei20466@126.com.

Zitieren

APA

Nanthachak, S., Wen, C., Gan, Z., Pan, L., Liu, R., & Huang, Y. (2026). Low- to moderate-dose thalidomide combination rescue after luspatercept failure in transfusion-dependent β-thalassemia: a real-world cohort study. Annals of Hematology. https://doi.org/10.1007/s00277-026-07100-2

Vancouver

Nanthachak S, Wen C, Gan Z, Pan L, Liu R, Huang Y. Low- to moderate-dose thalidomide combination rescue after luspatercept failure in transfusion-dependent β-thalassemia: a real-world cohort study. Annals of Hematology. 2026. doi:10.1007/s00277-026-07100-2

BibTeX
@article{Nanthachak2026,
  author = {Nanthachak, Soulivanh and Wen, Cailan and Gan, Zhaoping and Pan, Lingyuan and Liu, Rongrong and Huang, Yumei},
  title = {Low- to moderate-dose thalidomide combination rescue after luspatercept failure in transfusion-dependent β-thalassemia: a real-world cohort study},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-07100-2}
}
Kostenlos starten →